Absolutely. I will never waste my time with slop that doesn't get to the point. This is a lousy blog post about bread, not a great novel.
4,592 karma · joined December 7, 2011
https://www.science.org/content/blog-post/merck-and-moderna-...
>Postscript: Our Secretary of Health and Human Services of course cancelled $500 million in mRNA vaccine R&D contracts (22 different programs) last year, and cited a pile of misinformation (and cluelessly misunderstood research citations) to justify it. Our Director of the National Institutes of Health was apparently just fine with this decision and cited mRNA vaccines’ alleged failure to “earn public trust” as one of his reasons, along with public statements that “the mRNA platform is no longer viable”. I have a number of suggestions for each of these individuals and their supporters about how they might spend the rest of their day, and will be glad to send details if they contact me.
https://github.com/iOfficeAI/OfficeCLI
https://github.com/rcarmo/python-office-mcp-server
https://github.com/espressoplease/smalldocs
It would be great to see some benchmarks for token use, correctness, features etc.
>A standing reviewer agent. This runs in the background during a session, checking citations against sources, flagging numbers it can't trace back to evidence, and catching figures that don't match the code that supposedly generated them. That's not something Code or Cowork do automatically — you'd have to ask Claude to double-check itself as a separate step.
Nature Food is one of those also ran journals that sully the brand. None of my colleagues in related fields bother with it.
Eligibility requires history of relapse and refractory soft tissue sarcoma. Recruiting in US and Canada.
https://clinicaltrials.gov/study/NCT07156565?tab=researcher#...
https://roddenberry.x.io/2271-uss-enterprise-ncc-1701-major-...
The paper notes:
>It is important to note that MP products often contain elevated levels of nucleic acids, constituting ~8% of the dry weight [17], which necessitates consideration when assessing their suitability for human consumption. To address this, a heat treatment process is employed at the end of fermentation that reduces the nucleic acid content in the fermented biomass to below 0.75/100 g, while simultaneously deactivating protease activity and F. venenatum biomass. However, this procedure has been observed to induce cell membrane leakage and a substantial loss of biomass, as evidenced in the Quorn production process [17], which also utilizes F. venenatum as the MP producer. Our experimental trials have encountered similar challenges, achieving a biomass yield of merely ~35%, and observed that heating process increased the relative protein and chitin content (Figure 2D,E), which may be related to the effect of membrane leakage, while the intracellular protein of the FCPD engineered strain was less likely to be lost to the extracellular. Thus, concentrating the fermentation broth to enhance protein and amino acids content in successive steps to produce a highly nutritious water-soluble fertilizer appears to be an effective strategy for adding value to the process (Figure 1).
The challenges of developing economic single cell protein products, that are suitable for human consumption, are described in chapter 3 here:
https://www.researchgate.net/profile/Martin-Hofrichter-2/pub...
For youtube background play Brave is much better.